Opus Genetics News

S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 5 06:10

Ocuphire Pharma | 8-K: Current report

Oct 23 05:13

Ocuphire Pharma | 8-K: Current report

Jun 14 04:13

Ocuphire Pharma | DEFR14A: Definitive proxy statement in connection with contested solicitations

May 31 04:32

Ocuphire Pharma | 8-K: Current report

May 11 04:36

Ocuphire Pharma | DEF 14A: Definitive information statements

Apr 30 05:04

Ocuphire Pharma | DEFA14A: Others

Apr 30 04:46

Ocuphire Pharma | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 20 05:30

Ocuphire Pharma | 8-K: Current report

Apr 18 04:26

Ocuphire Pharma | 8-K: Current report

Mar 28 04:30

Ocuphire Pharma | 8-K: Current report

Feb 17 05:07

Ocuphire Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Jan 11 13:00

Ocuphire Pharma | S-3: Registration statement for specified transactions by certain issuers

Jan 10 13:00

Ocuphire Pharma | 8-K: Current report

Dec 6, 2023 08:15

Ocuphire Pharma | 8-K: Current report

Nov 27, 2023 21:45

Ocuphire Pharma | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Nov 21, 2023 08:52

Ocuphire Pharma | 8-K: Current report

Nov 2, 2023 20:44

Ocuphire Pharma | 8-K: Current report

Nov 2, 2023 04:21

Ocuphire Pharma | 8-K: Current report

Sep 27, 2023 20:45

Ocuphire Pharma | 8-K: Current report

Aug 11, 2023 21:27